2SX fundamentals
An in-depth look to SCPHARMACEUTICALS INC operating, investing, and financing activities
2SX free cash flow for Q1 24 is -16.41 M EUR. For 2023, 2SX free cash flow was -53.71 M EUR and operating cash flow was -53.68 M EUR.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM